欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/1258/001
药品名称Sodium Valproate Seacross 100mg/ml Solution for Injection or Infusion
活性成分
    • Sodium valproate 100.0 mg/ml
剂型Solution for injection/infusion
上市许可持有人Seacross Pharma (Europe) Ltd. Skybridge House Corballis Road North Dublin Airport Swords Co. Dublin K67 P6K2 Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Germany (DE)
      Natriumvalproat Seacross 100 mg/ml Injektions-/Infusionslösung
    • Netherlands (NL)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
许可日期2024/05/30
最近更新日期2025/05/12
药物ATC编码
    • N03AG01 valproic acid
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase